The Role of COVID-19 in Antibiotic Resistance in Pediatric Population by Kirill O. Kuznetsov, Laysan R. Tukbaeva, Valeriya V. Kazakova, Kamilla R. Mirzoeva, Ekaterina A. Bogomolova, Adelina I. Salakhutdinova, Darya Yu. Ponomareva, Aigul R. Garipova, Marina S.-M. Mutsolgova, Arslan G. Galimkhanov, Marsel I. Sakhibgareev, Elina R. Guzhvieva

“…All stakeholders (health authorities, regulating authorities, politicians, scientific community, pharmaceutical companies) have to collaborate and achieve results to implement all the mentioned above protection measures.…”
Get full text

Who is watching the World Health Organisation? ‘Post-truth’ moments beyond infodemic research by Travis M. Noake, David Bell, Timothy D. Noakes

“…In contrast, the division of labour for messenger ribonucleic acid (mRNA) vaccine research foregrounds the role of vaccine manufacturing pharmaceutical companies in driving and promoting related knowledge production. …”
Get full text

MSPEDTI: Prediction of Drug–Target Interactions via Molecular Structure with Protein Evolutionary Information by Lei Wang, Leon Wong, Zhan-Heng Chen, Jing Hu, Xiao-Fei Sun, Yang Li, Zhu-Hong You

“…Therefore, more and more pharmaceutical companies are trying to use computational technologies to screen existing drug molecules and mine new drugs, leading to accelerating new drug development. …”
Get full text

The Patent System During Global Pandemic and the Access to Medications and Vaccines by Fatou Diagne Mbaye, Agus Sardjono

“…The COVID-19 vaccine is owned by biotech companies, universities, research institutes or pharmaceutical companies. The purpose of this research is to analyse, through a normative juridical approach, the requirement for patent holders to protect their intellectual property rights if they are to remain competitive in the marketplace. …”
Get full text

Identification of Novel Antibacterials Using Machine Learning Techniques by Yan A. Ivanenkov, Yan A. Ivanenkov, Yan A. Ivanenkov, Yan A. Ivanenkov, Alex Zhavoronkov, Renat S. Yamidanov, Renat S. Yamidanov, Ilya A. Osterman, Ilya A. Osterman, Petr V. Sergiev, Petr V. Sergiev, Vladimir A. Aladinskiy, Vladimir A. Aladinskiy, Anastasia V. Aladinskaya, Anastasia V. Aladinskaya, Victor A. Terentiev, Victor A. Terentiev, Victor A. Terentiev, Mark S. Veselov, Mark S. Veselov, Mark S. Veselov, Andrey A. Ayginin, Andrey A. Ayginin, Victor G. Kartsev, Dmitry A. Skvortsov, Dmitry A. Skvortsov, Alexey V. Chemeris, Alexey Kh. Baimiev, Alina A. Sofronova, Alexander S. Malyshev, Gleb I. Filkov, Dmitry S. Bezrukov, Dmitry S. Bezrukov, Bogdan A. Zagribelnyy, Evgeny O. Putin, Maria M. Puchinina, Olga A. Dontsova, Olga A. Dontsova, Olga A. Dontsova

“…Many pharmaceutical companies are avoiding the development of novel antibacterials due to a range of rational reasons and the high risk of failure. …”
Get full text

Role of Trusted Sources and Behavioral Beliefs in Promoting Mitigation Behaviors During the COVID-19 Pandemic: Survey Study by Bridget L Hanson, Kari Finley, Jay Otto, Nicholas J Ward

“…ResultsUsing regression, masking intention was predicted by trust in the World Health Organization (P<.05) and participants’ state public health offices (P<.05), while vaccine willingness was predicted by trust in participants’ own health care providers (P<.05) and pharmaceutical companies (P<.001). Compared to individuals with low willingness to be vaccinated, individuals with high willingness indicated greater endorsement of beliefs that vaccines would support a return to normalcy, are safe, and are a social responsibility (P<.001 for all). …”
Get full text

Pharma 4.0: A deep dive top management commitment to successful Lean 4.0 implementation in Ghanaian pharma manufacturing sector by Michelle Grace Tetteh, Sumit Gupta, Mukesh Kumar, Hana Trollman, Konstantinos Salonitis, Sandeep Jagtap

“…Data collected from 181 employees of pharmaceutical companies in Ghana undergo analysis using SmartPLS (version 4) and IBM SPSS version 26. …”
Get full text

Open semantic annotation of scientific publications using DOMEO by Ciccarese Paolo, Ocana Marco, Clark Tim

“…Development of both the Annotation Framework and the open model was driven by requirements of several different types of alpha users, including bench scientists and biomedical curators from university research labs, online scientific communities, publishing and pharmaceutical companies.</p> <p>Several use cases were incrementally implemented by the toolkit. …”

Patient Preferences for Attributes of Chemotherapy for Lung Cancer: Discrete Choice Experiment Study in Japan by Yasuo Sugitani, Yasuo Sugitani, Kyoko Ito, Shunsuke Ono

“…As drug attributes can affect patient preferences, pharmaceutical companies should be aware of the patient preferences and develop drugs that respond to segmented market needs.…”
Get full text

An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic by A. N. Morozov, I. R. Yakhin, N. V. Stratonova, M. V. Kutskir, D. A. Poteryaev, R. A. Khamitov

“…A number of pharmaceutical companies faced the challenge of producing the vaccine. …”
Get full text

Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status by N. Maniadakis, G. Kourlaba, J. Shen, A. Holtorf

“…As economies grow, there should be greater investment in pharmaceutical care, looking to the policies of high-income countries to increase efficiency. Pharmaceutical companies could also develop special access schemes with low prices to facilitate coverage in low-income countries.…”
Get full text

Hypersensitivity Reaction of Tongue: Oral Adverse Effect of COVID-19 Vaccine: A Case Report by Sabarinath Balaraman, Ramya Sekar, Dhanarathna Shanmugam, Prabhu Shankar Dhayasankar

“…Based on the duration of symptoms, it has been classified into long COVID-19 and short COVID-19 to combat the outcome of the disease many vaccines were invented worldwide by various pharmaceutical companies and they helped a lot in controlling the severity of the disease. …”
Get full text

Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023 by Annalisa Landi, Giorgio Reggiardo, Antonella Didio, Annunziata D’Ercole, Adriana Ceci, Grace Shalom Govere, Donato Bonifazi, Fedele Bonifazi, Salvatore Crisafulli, Gianluca Trifirò, Florentia Kaguelidou, Katja Marja Hakkarainen, Katarina Gvozdanović, Francesco Barone-Adesi, Andrealuna Ucciero, Mariagrazia Felisi

“…As envisaged, the largest part was funded by pharmaceutical companies (62%). Anti-infectives for systemic uses (25%), medicines for the nervous system (18%), and antineoplastic and immunomodulating agents (15%) resulted in the most studied drugs. …”
Get full text

Potential risks to the National Health Service (NHS) of a Post-Brexit US Trade Deal by Louise Dalingwater

“…Moreover, in late November 2019, Jeremy Corbyn contended that Conservatives were negotiating a secret trade deal containing clauses which would open the NHS up to American pharmaceutical companies. The central focus of this paper is thus to examine the likely consequences of a post-Brexit trade deal between the US and the UK and to consider to what extent it could undermine the UK’s ability to provide a free, universal public health service. …”
Get full text

Analysis the Efficiency and Productivity of Indonesian Pharmaceutical Public Companies Using Data Envelopment Analysis by Dewi Hanggraeni

“…Lastly, technological change<br />contribution has more influence to productivity change instead of pure technical efficiency change in<br />Indonesia pharmaceutical companies.…”
Get full text

The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery by Natalia V. Segatto, Mariana H. Remião, Kyle M. Schachtschneider, Fabiana K. Seixas, Lawrence B. Schook, Lawrence B. Schook, Tiago Collares

“…The screening of potential therapeutic compounds using phenotypic drug discovery (PDD) is being embraced once again by researchers and pharmaceutical companies as an approach to enhance the development of new effective therapeutics. …”
Get full text

Drug labeling: The study of compliance of regulatory requirements for prescription drugs in India by Suchi Shah, Anil Singh

“…They were divided into two groups, each containing 50 drugs: (1) drug samples from drug store of a government hospital, manufactured for Gujarat government and (2) drug samples from PPs which are given to them by pharmaceutical companies. Each drug label was checked according to the criteria given under the D & CRs 1945, Section 96, 97. …”
Get full text

DETERMINANTS OF SOCIAL AND ENVIRONMENTAL ACCOUNTABILITY OF NIGERIAN FIRMS by Sani Damamisau Mohammed, Ruqayya Tijjani Ibrahim Muhammad

“…Results from the study indicated that corporate size statistically explain CSED by construction companies while leverage is significant in pharmaceutical companies. Corporate tax is negatively related with CSED in construction industry while other variables are not significant. …”
Get full text

Do Public Announcements of Drug Development Events Influence a Drug Company’s Market Value? A Study on Pfizer by Yu-Han Tsao, Chun-Chieh Wang

“…The results of this study can be useful for investors in the global stock market and for pharmaceutical companies exploring resource allocation in drug research and development strategies.…”
Get full text

Prospective and challenges of locally applied repurposed pharmaceuticals for periodontal tissue regeneration by Mohammad El-Nablaway, Mohammad El-Nablaway, Fatema Rashed, Ehab S. Taher, Ahmed Abdeen, Noha Taymour, Magdalen M. Soliman, Hany K. Shalaby, Liana Fericean, Bănățean-Dunea Ioan, Mohamed El-Sherbiny, Elturabi Ebrahim, Afaf Abdelkader, Mohamed Abdo, Mohamed Abdo, Cucui-Cozma Alexandru, Gamal A. Atia

“…This article clears the way in front of researchers, decision-makers, and pharmaceutical companies to explore the potential, effectiveness, and efficiency of the repurposed pharmaceuticals to generate more economical, effective, and safe topical pharmaceutical preparations for periodontal tissue regeneration.…”
Get full text